Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cognetivity Neurosciences Ltd C.CGN

Alternate Symbol(s):  CGNSF

Healthcare Medical Devices
Cognetivity Neurosciences Ltd. is a Canada-based technology company. The Company has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. It is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.


CSE:CGN - Post by User

Cognetivity Neurosciences Ltd > Could see $0.90 today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(105)
•••
Comment by tinkvidon Jul 04, 2021 8:35am
74 Views
Post# 33490494

RE:RE:RE:RE:RE:Could see $0.90 today

RE:RE:RE:RE:RE:Could see $0.90 today
The delta variant affects mostly the unvaxxed but could very well lead to another shutdown or a delay to reopening. If it materializes my average is very low and gives me ample time to react. But having no holdings in the potential here would be my biggest fear, especially with the announcements CGN has made, the share price could move north again with another material announcement....we'll see what happens.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities